A 62-year-old male smoker (40 pack-years) presents with progressive dyspnea on exertion and chronic cough productive of mucoid sputum for the past 3 years. He has been diagnosed with COPD (GOLD Stage 2, FEV₁ 55% predicted). On examination: barrel chest, pursed-lip breathing, oxygen saturation 94% on room air. Current medications include salbutamol PRN. Spirometry shows FEV₁/FVC ratio 0.58. He denies exacerbations in the past year. Which is the most appropriate next step in pharmacological management?

Explanation

## COPD Pharmacological Management by GOLD Stage **Key Point:** GOLD Stage 2 (moderate COPD, FEV₁ 50–79% predicted) with no exacerbations requires initiation of a long-acting bronchodilator—either LABA or LAMA monotherapy—as the foundational step. ### GOLD Treatment Algorithm | GOLD Stage | FEV₁ | Exacerbation History | Recommended Initial Therapy | |---|---|---|---| | 1 (Mild) | ≥80% | None | SABA PRN | | 2 (Moderate) | 50–79% | None | LABA or LAMA monotherapy | | 2 (Moderate) | 50–79% | ≥1 exacerbation/year | LABA/LAMA or ICS/LABA | | 3 (Severe) | 30–49% | Any | LABA/LAMA or ICS/LABA; consider triple | | 4 (Very Severe) | <30% | Any | Triple therapy (ICS/LABA/LAMA) | **High-Yield:** The patient is GOLD Stage 2 with **no exacerbations**—this is the key discriminator. Triple therapy (ICS/LABA/LAMA) is reserved for Stage 3–4 or Stage 2 with recurrent exacerbations (≥2 per year or ≥1 requiring hospitalization). ### Rationale for LABA or LAMA 1. **Improves lung function** and reduces symptoms compared to SABA alone. 2. **Reduces exacerbation risk** in moderate-to-severe COPD. 3. **First-line** for symptomatic Stage 2 COPD without exacerbation history. 4. LABA and LAMA have similar efficacy; choice depends on patient tolerance and comorbidities (e.g., LAMA preferred if concurrent asthma-COPD overlap). **Clinical Pearl:** Combination LABA/LAMA (dual bronchodilation) is preferred over monotherapy if the patient remains symptomatic on single agent, but initial monotherapy is standard for newly diagnosed Stage 2 COPD. **Mnemonic: GOLD Escalation** — **S**ABA → **L**ABA/**L**AMA → Dual BD → Triple (ICS/LABA/LAMA) [cite:Harrison 21e Ch 254]